Search results for "Meter"

showing 10 items of 16915 documents

Salmeterol Xinafoate (SX) loaded into mucoadhesive solid lipid microparticles for COPD treatment

2019

Chronic obstructive pulmonary disease (COPD) is one of the main health problems worldwide. It is characterised by chronic inflammation in the lungs that leads to progressive, chronic, largely irreversible airflow obstruction. The use of long-acting β agonists remain today the frontline treatment for COPD with the aim of minimizing side effects and enhancing therapeutic usefulness. To this purpose, in this paper, mucoadhesive solid lipid microparticles (SLMs) containing a long-acting β-2 agonist, Salmeterol Xinafoate (SX) were prepared, characterised (size, z-potential, aerodynamic diameter, turbidimetric evaluations, drug loading and entrapping efficiency) and tested in a model of bronchial…

3003AgonistDrugAlginatesCell Survivalmedicine.drug_classmedia_common.quotation_subjectSodium alginate polymerPharmaceutical ScienceChronic obstructive pulmonary disease (COPD)Inflammation02 engineering and technologyPharmacology030226 pharmacology & pharmacyCell LinePulmonary Disease Chronic Obstructive03 medical and health sciences0302 clinical medicinecAMPmedicineHumansAerodynamic diameterAdrenergic beta-2 Receptor AgonistsSalmeterol Xinafoatemedia_commonDrug CarriersCOPDInhalationChemistryTherapeutic effectAdhesiveness021001 nanoscience & nanotechnologymedicine.diseaseLipidsSALMETEROL XINAFOATEBronchodilator Agentsrespiratory tract diseasesSalmeterol Xinafoate (SX)MucusAerodynamic diametermedicine.symptom0210 nano-technologyInternational Journal of Pharmaceutics
researchProduct

CCDC 780775: Experimental Crystal Structure Determination

2011

Related Article: K.Raatikainen, N.K.Beyeh, K.Rissanen|2010|Chem.-Eur.J.|16|14554|doi:10.1002/chem.201001695

363942-tris((ethylcarbamoyl)amino)-92031-triaza-11223-triazoniaheptacyclo[29.2.2.2^912^.2^2023^.1^37^.1^1418^.1^2529^]dotetraconta-3(42)4614(39)151725(36)2628-nonaene dihydrogen phosphate hydrogen phosphate methanol solvate tetrahydrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 666841: Experimental Crystal Structure Determination

2008

Related Article: K.Raatikainen, J.Huuskonen, E.Kolehmainen, K.Rissanen|2008|Chem.-Eur.J.|14|3297|doi:10.1002/chem.200701862

3^2^7^2^11^2^15^2^-Tetraamino-15913(14)-tetrapiperazina-371115(13)-tetrabenzenacyclohexadecaphane acetonitrile clathrate dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1437668: Experimental Crystal Structure Determination

2015

Related Article: M. Akhazzane, G. Al Houari, M. El Yazidi, M. Saadi, L. El Ammari|2015|Acta Crystallogr.,Sect.E:Cryst.Commun.|71|o981|doi:10.1107/S2056989015022033

4'-(4-methoxyphenyl)-44-dimethyl-3'-(4-methylphenyl)-34-dihydro-1H4'H-spiro[naphthalene-25'-[12]oxazol]-1-oneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 1537522: Experimental Crystal Structure Determination

2017

Related Article: Pankaj Chauhan, Suruchi Mahajan, Uğur Kaya, Anssi Peuronen, Kari Rissanen, and Dieter Enders|2017|J.Org.Chem.|82|7050|doi:10.1021/acs.joc.7b01113

4'-[(t-butoxycarbonyl)amino]-33'-dimethyl-5'-oxo-11'-diphenyl[4'5'-dihydro-1H1'H-[44'-bipyrazole]]-5-yl acetateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 104281: Experimental Crystal Structure Determination

1997

Related Article: J.Ratilainen, K.Airola, M.Nieger, M.Bohme, J.Huuskonen, K.Rissanen|1997|Chem.-Eur.J.|3|749|doi:10.1002/chem.19970030515

41016-Tri(14)benzena-359111517-hexaoxa-1713-tri(26)pyridinaoctadecaphane monohydrate clathrateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 149238: Experimental Crystal Structure Determination

2001

Related Article: S.Mahboobi, I.Dechant, H.Reindl, H.Pongratz, A.Popp, D.Schollmeyer|2000|J.Heterocycl.Chem.|37|307|doi:10.1002/jhet.5570370215

431-Dimethyl-1414213134-hexaaoctacyclo(32.2.2.0-^26^.0^715^.0^813^.0^2028^.0^2227^.0^2933^)octatriaconta-2(6)7(15)8(13)91120(28)22(27)232529(33)-decaene-353032-tetraone tetrahydrofuran solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 612661: Experimental Crystal Structure Determination

2009

Related Article: E.W.Reinheimer, J.R.Galan-Mascaros, K.R.Dunbar|2009|Synth.Met.|159|45|doi:10.1016/j.synthmet.2008.07.017

44'55'-Tetramethyl-11'33'-tetrathiafulvalene 247-trinitro-9H-fluoren-9-oneSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 2022360: Experimental Crystal Structure Determination

2021

Related Article: Abdullah Mohammed Al-Majid, Matti Haukka, Saied M. Soliman, Abdullah Saleh Alamary, Saeed Alshahrani, M. Ali, Mohammad Shahidul Islam, Assem Barakat|2021|Symmetry|13|20|doi:10.3390/sym13010020

44'-(ethane-12-diyl)bis(morpholine)Space GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct

CCDC 685282: Experimental Crystal Structure Determination

2009

Related Article: A.Jahel, N.V.Vologdin, N.Pirio, H.Cattey, P.Richard, P.Meunier, J.-C.Hierso|2008|Dalton Trans.||4206|doi:10.1039/b809244n

44'-Di-t-butyl-22'-bis(diphenylphosphino)-11'-bis(diphenylphosphonium)ferrocene bis(pentachloro-(tetrahydrofuran)-zirconium) dichloromethane solvateSpace GroupCrystallographyCrystal SystemCrystal StructureCell ParametersExperimental 3D Coordinates
researchProduct